Potent antitumor activity of cabozantinib, a c‐<scp>MET</scp> and <scp>VEGFR</scp>2 inhibitor, in a colorectal cancer patient‐derived tumor explant model
Eun‐Kee Song(Jeonbuk National University Hospital), John J. Arcaroli(University of Colorado Denver)
Cited by 61
Related Papers
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
|The Lancet Oncology|2020|190
Variant IRAK-1 Haplotype is Associated with Increased Nuclear Factor–κB Activation and Worse Outcomes in Sepsis
|American Journal of Respiratory and Critical Care Medicine|2006|139
Extracellular Superoxide Dismutase Haplotypes Are Associated with Acute Lung Injury and Mortality
|American Journal of Respiratory and Critical Care Medicine|2008|54